Strides Pharma Science Ltd

Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide		Download
4-Feb-21 Motilal Oswal Slower US/Africa biz drag down earnings Buy 887 980 10.48
30-Oct-20 Motilal Oswal 2Q – COVID-led aberration hurts performance Buy 673 790 17.38
30-Jan-20 Motilal Oswal Reset strategy + product-specific opportunity drive earnings Buy 469 550 17.27
11-May-19 Motilal Oswal Operating leverage kicks in; earnings growth set to revive Buy 485 635 30.9
14-Mar-18 Motilal Oswal ANDA approval momentum intact Buy 692 989 42.9

Upcoming Events and Recent Updates

No Recent Updates.

Analyst Calls / Meets


Management Interviews

01-Feb-24 Arun Kumar, MD  
31-Oct-23 Arun Kumar, MD  
26-Sep-23 Arun Kumar, MD  
11-Nov-21 R Ananthanaraya..  
28-May-21 R Ananthanaraya..  

Investor Presentations

30-Jan-24 Investor/Anal...
30-Oct-23 Investor/Anal...
02-Aug-23 Investor/Anal...
24-Jan-23 Investor/Anal...
10-Feb-22 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2022-23  
2021-22  
2020-21  
2019-20  
2018-19  

Research Showcase

04-Feb-21
Motilal Oswal -..
Download
30-Oct-20
Motilal Oswal -..
Download
30-Jan-20
Motilal Oswal -..
Download
11-May-19
Motilal Oswal -..
Download
14-Mar-18
Motilal Oswal -..
Download

Post IT's


Results

30-Jan-24 Results
30-Oct-23 Results
02-Aug-23 Results
25-May-23 Results
24-Jan-23 Results

AGM/EGM/Board Meetings

20-Aug-20 - AGM
05-Aug-20 - Quarterly Results
20-May-20 - Audited Results & Divi..
20-Feb-20 - COM
25-Nov-19 - POM

Company Announcements


Press Release

05-Mar-24 Press Release
30-Jan-24 Press Release
01-Dec-23 Press Release
23-Nov-23 Press Release
30-Oct-23 Press Release